Ionis Pharmaceuticals
IONS
173 hedge funds and large institutions have $2.84B invested in Ionis Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 173 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
86.9% more ownership
Funds ownership: 0% → 86.9% (+87%)
20% more call options, than puts
Call options by funds: $36M | Put options by funds: $30.1M
Top Buyers
Top Sellers
IONS Hedge Fund Activity: Q2 2013 in Review
173 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q2 2013, worth a combined $2.84B.
Buyers outnumbered sellers: 173 funds opened new IONS positions and 0 closed out — a net gain of 173 holders — while 0 added to existing stakes and 0 trimmed.
- 173 institutional investors held Ionis Pharmaceuticals (IONS) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $2.84B of Ionis Pharmaceuticals stock for Q2 2013.
- 173 funds opened new Ionis Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +173 holders.
Based on aggregated 13F filings for Q2 2013.